Impacts of the Long‐Term Low‐FODMAP Diet in Patients With Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis
Journal of Human Nutrition and Dietetics · 2025
DOI: 10.1111/jhn.70105 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Human Nutrition and Dietetics, 2025. Verfasst von Amirreza Pouladi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Liver Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Science…. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Diet, Carbohydrate-Restricted. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background and Objectives The low fermentable oligo‐, di‐, monosaccharides and polyols diet (LFD) is the primary intervention for managing irritable bowel syndrome (IBS). However, due to its restrictive nature, concerns have been raised about its safety and efficacy with long‐term use. This study aims to investigate the outcomes of long‐term LFD (LLFD) in patients with IBS.
Methods
A systematic search was performed in PubMed, Embase and Scopus up to November 2024. LLFD was defined as LFD for at least 6 months. A random‐effects model was applied to estimate the standardised mean difference (SMD) and 95% confidence interval (95% CI) for each outcome. The protocol of the study was registered in PROSPERO (ID CRD42024609338).
Results
Of the total 2724 screened records, five studies finally met the inclusion criteria and were included in the study (324 patients). LLFD was able to reduce overall gastrointestinal symptoms (SMD −1.97, 95% CI −3.63 to −0.30), anxiety (SMD −0.40, 95% CI −0.65 to −0.15) and depression (SMD −0.28, 95% CI −0.53, to −0.03). Additionally, LLFD improved quality of life (mean difference 0.53, 95% CI 0.24–0.83). However, it was not able to improve the quality of sleep (SMD −0.13, 95% CI −0.39 to 0.12).
Conclusions
The long‐term use of LFD appears effective in improving gastrointestinal symptoms, psychological well‐being, and quality of life in patients with IBS. Further research is needed to confirm these findings and explore additional long‐term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology and Liver Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Student Research Committee, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Amirreza Pouladi
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Pouladi, A., Arabpour, E., Bahrami, O., Sadeghi, A., Mozafari Komesh Tape, P., Abdehagh, M., & Zali, M. R. (2025). Impacts of the Long‐Term Low‐FODMAP Diet in Patients With Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis. Journal of Human Nutrition and Dietetics. https://doi.org/10.1111/jhn.70105
Vancouver
Pouladi A, Arabpour E, Bahrami O, Sadeghi A, Mozafari Komesh Tape P, Abdehagh M, et al. Impacts of the Long‐Term Low‐FODMAP Diet in Patients With Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis. Journal of Human Nutrition and Dietetics. 2025. doi:10.1111/jhn.70105
BibTeX
@article{Pouladi2025,
author = {Pouladi, Amirreza and Arabpour, Erfan and Bahrami, Omid and Sadeghi, Amir and Mozafari Komesh Tape, Parya and Abdehagh, Mohammad and Zali, Mohammad Reza},
title = {Impacts of the Long‐Term Low‐FODMAP Diet in Patients With Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis},
journal = {Journal of Human Nutrition and Dietetics},
year = {2025},
doi = {10.1111/jhn.70105}
}
EUVIMED